News

As we come out the other side of the COVID-19 pandemic, a webinar hosted by the International Diabetes Federation (IDF) focused on the challenges and lessons learned in different parts of the world. Lisa Buc...

A new study in Diabetologia looks at the impact of bariatric surgery on three different diabetes complications. The findings suggest that surgery could be an effective approach for reducing peripheral neurop...

The COVID-19 pandemic forced diabetes clinics to go online at short notice. The benefits and challenges involved in the continuing use of telemedicine in diabetes care were in the spotlight at the recent Adv...

While physical exercise is good for people with type 1 diabetes, it does carry a risk of hypoglycaemia, which is why it may be necessary to reduce insulin doses afterwards. However, the ADREM (Adjustment of ...

People at risk of type 1 diabetes can be identified before symptoms occur, reducing the risk of an emergency diagnosis. Initiatives around the world looking at population-based screening for the condition we...

In EASD e-Learning’s latest module, which launches today, Professor Eelco de Koning examines the different patient journeys for islet transplantation that are available to people with diabetes, accordi...

What should people eat to manage or prevent type 2 diabetes? The complexity of food has led to confusion over what is healthy, unhealthy or optimal among healthcare professionals and the public alike. Howeve...

Many factors, including ethnicity, location and socioeconomic status, contribute to disparities in diabetes care and it is important that these are addressed to improve clinical outcomes and quality of life ...

Cancer is overtaking cardiovascular disease as a leading cause of death in people with type 2 diabetes. A new paper in Diabetologia looks at trends in cancer mortality in England over a 20-year period and it...

With the increasing use of continuous glucose monitoring (CGM) in people with diabetes, glucose metrics are starting to complement HbA1c in both diabetes care and clinical trials. To reduce the risk of compl...

Cardiovascular disease (CVD) is more common in people with type 1 and type 2 diabetes than among the general population. The increasing global burden of diabetes means that many more people are now at risk o...

The Hypo-RESOLVE consortium is dedicated to developing new tools to investigate the impact of hypos and to find solutions to improve the lives of people with diabetes. New Hypo-RESOLVE studies on the psychos...

Bariatric surgery can put type 2 diabetes into remission, but it’s not without complications, including hypoglycaemia after meals. A new study in Diabetologia sheds some light on the underlying pathoph...

Many people with diabetes would like to reduce the number of insulin injections they need, which is why the development of weekly insulins has been watched with great interest. Findings from recent clinical ...

As rates of type 2 diabetes and prediabetes continue to soar, so too are rates of cardiorenal complications. What can we do to tackle this globally significant health challenge? For the third episode in our ...

Poor glycaemic control before and during pregnancy can increase the risk of congenital malformations and perinatal death among the offspring of women with type 1 diabetes. A new analysis of real-world data, ...

Automated insulin delivery (AID) within hybrid closed loop systems is starting to take centre stage in diabetes management. Findings from recent AID studies in a real-world setting in France, Belgium and Eng...

People’s beliefs about hypoglycaemia were explored as part of the HypoCOMPaSS trial, which aimed to help those with impaired awareness reduce their rate of severe hypos. The findings, reported in a rec...

The wider use of continuous glucose monitoring (CGM) raises questions about the significance of low glucose readings. According to findings presented at the recent Advanced Technologies & Treatments for ...

The risk of progression to clinical diabetes after initial decline in beta cell function depends on age, according to a paper in a recent issue of Diabetologia. The researchers have mapped the trajectory of ...

People with type 2 diabetes often start on non-insulin glucose-lowering medication but, as their condition progresses, they may need insulin. Dr Lalantha Leelarathna, consultant diabetologist at the Manchest...